Burden of vaccine-preventable pneumococcal disease in hospitalized adults: A Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS) network study

Highlights • Active CAP and IPD surveillance was conducted in hospitalized adults since 2010. • Severe outcomes and mortality is seen with CAP and IPD in hospitalized adults. • The serotype distribution suggests most disease in adults is vaccine-preventable. • The incidence of vaccine-preventable pn...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Vaccine 2017-06, Vol.35 (29), p.3647-3654
Hauptverfasser: LeBlanc, Jason J, ElSherif, May, Ye, Lingyun, MacKinnon-Cameron, Donna, Li, Li, Ambrose, Ardith, Hatchette, Todd F, Lang, Amanda L, Gillis, Hayley, Martin, Irene, Andrew, Melissa K, Boivin, Guy, Bowie, William, Green, Karen, Johnstone, Jennie, Loeb, Mark, McCarthy, Anne, McGeer, Allison, Moraca, Sanela, Semret, Makeda, Stiver, Grant, Trottier, Sylvie, Valiquette, Louis, Webster, Duncan, McNeil, Shelly A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Highlights • Active CAP and IPD surveillance was conducted in hospitalized adults since 2010. • Severe outcomes and mortality is seen with CAP and IPD in hospitalized adults. • The serotype distribution suggests most disease in adults is vaccine-preventable. • The incidence of vaccine-preventable pneumococcal CAP by age was estimated. • Most vaccine-preventable pneumococcal disease is seen in adults aged ≥50 years.
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2017.05.049